A Pilot Study on the Effects of ILARIS® on Patients With Proliferative Diabetic Retinopathy (PDRP) (ILARIS)

This study has been terminated.
(The results of the interim analysis showed that the primary endpoint was not met)
Sponsor:
Collaborators:
Novartis
University Hospital, Zürich
Information provided by (Responsible Party):
PD Dr. med. Stephan Michels, Triemli Hospital
ClinicalTrials.gov Identifier:
NCT01589029
First received: April 27, 2012
Last updated: November 23, 2015
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2014
  Primary Completion Date: November 2014 (Final data collection date for primary outcome measure)